worldVIEW: Scorecard Data Points

Scorecard Data Points

The 2011 Scientific American Worldview Overall Scores
Assessing 48 countries on their overall capabilities to generate innovation in biotechnology by The Editors
Top-5 Talk
by The Editors
Building for the Bottom-5
by The Editors
Three Years of Biotech Tracking
Exploring innovation trends around the world by The Editors
Building a Diverse Industry in Brazil
Working its way up in an extremely competitive international field by The Editors
The Best of the Best in Biotechnology
If the industry awarded Biotech Oscars, this world map would showcase those countries taking a leading role in a variety of categories by The Editors
Medical Markets on the Move
Today's leaders in the pharmaceutical market face growing competition by The Editors
Comparing Corruption
A lack of honest business practices can decelerate innovation by The Editors
Producing Patents
Building a foundation for biotechnology innovation by The Editors
Publishing Counts
Highly-cited peer-reviewed articles indicate a country’s intellectual power by The Editors
Bullish on Biologics
Much of the growth in the pharmaceutical industry relies on bigger molecules rather than smaller ones by The Editors
You Get What You Pay For
The sales volume of biologics in a country influences how many biologics its citizens can access by The Editors
Dissecting the Drug Lag
Countries that pay more for drugs get new drugs faster by The Editors
R&D Dollars
Investing in biotechnology R&D drives innovation by The Editors
People in Public Biotech
The number of public companies and employees sort out the leaders by The Editors
Analyzing the Outputs
Public-company data show which countries generate the most biotech business by The Editors

2: Intensity
Measuring a country's biotech "blood pressure" demands multiple approaches
3: Enterprise Support
Biotechnology thrives only when a country maintains a broad collection of business resources

Worldview Scorecard

Honduras	Saudi Arabia
Hungary	Switzerland
Ireland	Uganda
Italy	U.S.
Japan	Vietnam

Country Spotlights

Brighter Days Ahead
A variety of tools—from emerging-market opportunities to mergers and acquisitions—help companies grow in a recovering market
More Angles for an Expanding Story

Perspectives

The Elements of Service
A Chinese CEO develops end-to-end contract research and manufacturing capabilities
Building the Critical Mass
A Brazilian CEO turned venture capitalist makes multiple contributions to the biotech field

Profiles